vTv Therapeutics (VTVT) FCF Margin (2016 - 2024)
Historic FCF Margin for vTv Therapeutics (VTVT) over the last 10 years, with Q4 2024 value amounting to 28382.35%.
- vTv Therapeutics' FCF Margin changed N/A to 28382.35% in Q4 2024 from the same period last year, while for Sep 2025 it was 122523.53%, marking a year-over-year decrease of 1201839300.0%. This contributed to the annual value of 2488.4% for FY2024, which is N/A changed from last year.
- Per vTv Therapeutics' latest filing, its FCF Margin stood at 28382.35% for Q4 2024.
- In the past 5 years, vTv Therapeutics' FCF Margin ranged from a high of 7844.44% in Q2 2022 and a low of 77628.57% during Q3 2020
- Moreover, its 4-year median value for FCF Margin was 14557.93% (2024), whereas its average is 30109.08%.
- In the last 5 years, vTv Therapeutics' FCF Margin skyrocketed by 839082900bps in 2020 and then crashed by -712654300bps in 2021.
- Quarter analysis of 4 years shows vTv Therapeutics' FCF Margin stood at 34.57% in 2020, then crashed by -206161bps to 71300.0% in 2021, then dropped by -7bps to 76444.44% in 2022, then skyrocketed by 63bps to 28382.35% in 2024.
- Its last three reported values are 28382.35% in Q4 2024, 733.5% for Q1 2024, and 76444.44% during Q4 2022.